Free shipping on all orders over $ 500

 About 1 result found for searched term "PF-06835919" (0.138 seconds)

Cat.No.  Name Target
M21287 PF-06835919 Ketohexokinase
Ketohexokinase inhibitor 1
PF-06835919 is an oral Class I clinical candidate for NAFLD/NASH, targeting ketohexokinase (KHK), an enzyme that initiates fructose metabolism.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.